Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
LCP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
EN2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
MXRA7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
FCMR - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC101060835 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ATP7B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BNIP3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HDAC6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CNKSR1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
C7orf13 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PLXNA4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZDHHC14 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DIP2C - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ST14 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TADA2B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BSPRY - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PARVB - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NACC2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on